Arkolith/Insider Trading/EVLO/Form 4

Thorell Marella

Chief Financial OfficerEvelo Biosciences, Inc. (EVLO) · full profile →Form 4 · filed Aug 9, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$19K
Net Open-Market Flow
-$19K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2023Sell(S)2K$9.51$19K9K
Aug 7, 2023Option exercise(M)7K——11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 7, 2023Option exercise(M)7K—$013K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001694665-23-000133) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML